Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
11.89
+0.60 (5.31%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Orthofix Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -60.01 | -92.19 | -126 | -151.4 | -19.75 | -38.38 |
Depreciation & Amortization | 56.38 | 77.32 | 60.06 | 53.06 | 29.02 | 29.6 |
Stock-Based Compensation | 28.75 | 28.69 | 32.46 | 35.71 | 18.44 | 15.43 |
Other Adjustments | 30.56 | 41.03 | 78.52 | 70.84 | 4.89 | 47.35 |
Change in Receivables | -6.93 | -1.58 | -9.53 | -10.41 | -6.74 | -7.05 |
Changes in Inventories | -20.29 | -10.75 | -5.55 | -58.05 | -33.04 | -10.21 |
Changes in Accounts Payable | 0.72 | 2.6 | -5.57 | 8.64 | 2.28 | 4.25 |
Changes in Accrued Expenses | 13.9 | -2.27 | 9.53 | 4.07 | 0.63 | 1.01 |
Changes in Unearned Revenue | - | - | - | - | -4.79 | -9.06 |
Changes in Other Operating Activities | -7.63 | -9.5 | -8.14 | 1.79 | -2.49 | -14.47 |
Operating Cash Flow | 34.13 | 33.35 | 25.79 | -45.75 | -11.54 | 18.48 |
Operating Cash Flow Growth | 31.29% | 29.30% | - | - | - | -75.13% |
Capital Expenditures | -38.55 | -34.63 | -34.88 | -62.05 | -21.36 | -17.79 |
Purchases of Intangible Assets | - | - | - | - | -1.8 | -1.81 |
Purchases of Investments | - | - | - | - | - | -2.17 |
Proceeds from Sale of Investments | - | - | 7.4 | - | - | - |
Payments for Business Acquisitions | - | - | - | 29.42 | -1.5 | - |
Other Investing Activities | 0.17 | 0.03 | -0.1 | -0.5 | 0.13 | -1.25 |
Investing Cash Flow | -38.38 | -34.6 | -27.58 | -33.13 | -24.53 | -23.01 |
Long-Term Debt Issued | 64.03 | - | 197.6 | 174.5 | - | - |
Long-Term Debt Repaid | - | - | -142.5 | -105.9 | - | - |
Net Long-Term Debt Issued (Repaid) | 64.03 | - | 55.1 | 68.6 | - | - |
Issuance of Common Stock | 5.88 | 5.93 | 6.26 | 5.13 | 4.34 | 8.82 |
Repurchase of Common Stock | -0.43 | -0.43 | -5.31 | -4.4 | -1.73 | -2.56 |
Net Common Stock Issued (Repurchased) | 5.45 | 5.5 | 0.95 | 0.73 | 2.61 | 6.27 |
Other Financing Activities | -0.65 | -6.28 | -5.34 | -4.01 | -2.69 | -9.89 |
Financing Cash Flow | 63.84 | -0.79 | 50.71 | 65.32 | -0.08 | -3.62 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.83 | 1.41 | -0.94 | 0.62 | -1 | -0.82 |
Net Cash Flow | 60.42 | -0.62 | 47.98 | -12.94 | -37.15 | -8.97 |
Free Cash Flow | -4.42 | -1.28 | -9.09 | -107.8 | -32.9 | 0.69 |
Free Cash Flow Growth | - | - | - | - | - | -98.83% |
FCF Margin | -0.54% | -0.16% | -1.14% | -14.44% | -7.14% | 0.15% |
Free Cash Flow Per Share | -0.11 | -0.03 | -0.24 | -2.94 | -1.63 | 0.03 |
Levered Free Cash Flow | 8.56 | -69.41 | -55.44 | -135.33 | -49.5 | -55.04 |
Unlevered Free Cash Flow | 5.03 | -59.89 | -70.61 | -194.19 | -44.55 | -40.31 |